The comparison between AgB-ELISA and a new method of Nano-ELISA for diagnosis of hydatidosis in sheep


Published: Apr 29, 2022
Keywords:
Nano-ELISA Antigen B hydatid cysts
Shahrokh Shirazi
https://orcid.org/0000-0001-6819-5391
Nasser Hoghooghi-Rad
https://orcid.org/0000-0003-1773-3502
Rasoul Madani
https://orcid.org/0000-0002-8202-7025
Abstract

Hydatidosis is one of the most important zoonotic diseases, and it is transmitted via dogs to intermediate hosts such as humans and domestic animals including sheep and cattle. Epidemiological studies and genetic investigations indicate that the sheep strain is the most common species causing hydatid cysts in humans. The prevalence and incidence of this disease are increasing. According to surveys, economic losses due to this parasite in intermediate hosts are significant. In this survey, 25 serum samples were obtained from newborn lambs as negative control and obtained 25 serum samples from infected sheep to hydatidosis as the positive control. Antigen B isolated from hydatid cysts fluid was used for designing ELISA methods. Using Antigen B in ELISA design for hydatidosis diagnosis has attracted researchers in recent years. During this study, an Iranian native B antigen was used to design the specific detection of hydatidosis in sheep using a specific ELISA technique. The first method used the anti-Sheep conjugate (SIGMA, at 1:3000 dilution), and the second method used gold nanoparticles in combination with anti-sheep conjugate. According to the results, sensitivity and specificity in sheep of the AgB-ELISA method were both 92% and for the Nano-ELISA with Gold Nanoparticles 100% and 96%, respectively. Moreover, results indicated that using Antigen B in ELISA design is valuable but specificity and sensitivity will increase significantly, especially in lower titer, when gold nanoparticles with anti-sheep conjugate are used.

Article Details
  • Section
  • Research Articles
Downloads
Download data is not yet available.
References
Ambrosi A, Airo F, Merkoci A (2010) Enhanced Gold Nanoparticle Based ELISA for a Breast Cancer Biomarker. Anal Chem 82: 1151-1156.
Asghari M, Mohebali M, Kia E B, Farahnak A, Arianipour M, Asadian S, Rokni MB (2013) Seroepidemiology of Human Hydatidosis Using AgB-ELISA Test in Arak, Central Iran. Iran J Publ Health 42(4): 391-396.
Azami M, Anvarinejad M, Ezatpour B, Alirezaei M (2013) Prevalence of hydatidosis in slaughtered animal in Iran. TurkiyeParazitolDerg 37: 102-6.
Bhutania N, Kajal P (2018) Hepatic echinococcosis: A review. Anal of Med and Surgery 36: 99–105
Barnes TS, Deplazes P, Gottstein B, Jenkins DJ, Mathis A, Siles-Lucas M, et al (2012) Challenges for diagnosis and control of cystic hydatid disease. Acta Trop 123: 1– 7.
Beard, T.C., 1973. The elimination of echinococcosis from Iceland. Ball World Health organ 48(6): 653-60.
Brunetti E, Kern P, Vuitton DA (2010) Writing Panel for the WHO-IWGE. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 114: 1-6.
Cho IH, Irudayari J (2013) In-situ immune-gold nanoparticle network ELISA biosensors for pathogen detection. Int J Food Micro 164: 70-75.
Fasihi-Harandi M, Budke CM, Rostami S (2012) The Monetary Burden of Cystic Echinococcosis in Iran. PLoSNegl Trop Dis 6(11): 1-10.
Grosso G, Gruttadauria S, Biondi A, Marventano S, Mistretta A (2012) Worldwide epidemiology of liver hydatidosis including the Mediterranean area. World J Gastroenterol 18(13): 1425-1437.
Jahani Z, Meshghi B, Rajabi M, Jalousian F, Hasheminasab S (2014) Improved Serodiagnosis of Hydatid Cyst Disease Using Gold Nanoparticle Labeled Antigen B in Naturally Infected Sheep. Iran J Parasitol 9(2): 218-225.
Jawad AR, Sulbi, IM, Jameel YJ (2018) Epidemiological study of the prevalence of hydatidosis in ruminants at the Holy City of Karbala, Iraq.Anal Parasitol 64(3): 211–215.
KordAfshari S, Hosseinin SH, Jalousian F, RajabiBazl M, et al (2015) Evaluation of Dot Immunogold Filtration Assay (DIGFA) By Recombinant Protein EPC1 for Anti- Echinococcus granulosus IgG Antibody.Iran J Parasitol 10(1): 30-38.
Mahmoudi S, Mamishi S, Banar M, Pourakbari B, Keshavarz H (2019) Epidemilogy of echinococcosis in Iran, a systematic review and meta-analysis. BMC Infec Dis 19:929.
Mandal S, Mandal MD (2011) Human cystic echinococcosis: epidemiologic, zoonotic, clinical, diagnostic and therapeutic aspects. Asian Pac J Trop Med 253-260.
Paykari H, KarimiGhR, MotamediGhR, Abshar N, Navidpour S (2007) A serological survey for hydatidosis among buffaloes in Orumia. Arch RaziInst 62 (2): 101-104.
Rokni MB (2009) Echinococcosis /hydatidosis in Iran. Iran J Parasitol 4(2): 1-16.
Sharafi SM, Rostami-Nejad M, Moazaen M, Yousefi M, et al (2014) Echinococcus granulosus genotypes in Iran. GastroenterolHepatol Bed Bench 7(2):82-88).
Shirazi S, Madani R, HoghooghiRad N, RanjbarBahadori S (2016) Isolation and purification of Echinococcus granulosus antigen B from hydatid cyst fluid using three different methods. Arch RaziInst 71(2): 103-108.